BioCentury | Jun 29, 2015
Company News

Cardiff University, Tiziana Life Sciences deal

...The university granted Tiziana exclusive, worldwide rights to small molecule OH14 . Tiziana plans to develop...
...FLICE-like inhibitory protein (c-FLIP) inhibitor for cancer. The company plans to start clinical testing of OH14...
...receive EUR50,000 ($56,630) per year to research structure activity relationships surrounding OH14 and to improve OH14’s...
Items per page:
1 - 1 of 1